Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | HCAR3 | P49019 | 13/20 | 0.60 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL6523817 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6523810 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6512633 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6512645 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6512650 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL23699471 | 0.87 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6512637 | 0.85 | CASP6 (0.53) | CASP6TSHRLMNAHCAR3APEX1 | |
| Zinc Ion SCHEMBL6523813 | 0.85 | CASP6 (0.53) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL6512981 | 0.85 | MAPT (0.54) | CASP6TSHRLMNAHCAR3 | |
| SCHEMBL6516066 | 0.85 | CASP6 (0.53) | CASP6TSHRLMNAHCAR3APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | claimed |
| US-12245446-B2 | Semiconductor device having quantum dots, display device, imaging system, and moving body | CANON KABUSHIKI KAISHA (JP) | 2025-03-04 | — | — | US | disclosed |
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | disclosed |
| EP-3781574-B1 | MACROCYCLIC SPIROETHERS AS MCL-1 INHIBITORS | ASCENTAGE PHARMA SUZHOU CO LTD (CN) | 2023-05-10 | — | — | EP | disclosed |
| CN-215102081-U | Treatment system containing nitric acid system | 山东友道化学有限公司 | 2021-12-10 | — | — | CN | disclosed |
| US-20210340158-A1 | MACROCYCLIC SPIROETHERS AS MCL-1 INHIBITORS | ASCENTAGE PHARMA GROUP CORP LIMITED (CN) | 2021-11-04 | — | — | US | disclosed |
| CN-113285024-A | Semiconductor device having quantum dots, display device, imaging system, and moving object | 佳能株式会社 | 2021-08-20 | — | — | CN | disclosed |
| US-20210242416-A1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS, DISPLAY DEVICE, IMAGING SYSTEM, AND MOVING BODY | CANON KABUSHIKI KAISHA (JP) | 2021-08-05 | — | — | US | disclosed |
| EP-3859804-A2 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KABUSHIKI KAISHA (JP) | 2021-08-04 | — | — | EP | disclosed |
| EP-3292893-B1 | GOLF BALL | SUMITOMO RUBBER IND (JP) | 2021-06-09 | — | — | EP | disclosed |
| CN-102526995-A | Golf ball | SRI SPORTS LTD | 2012-07-04 | — | — | CN | disclosed |
| US-20120142453-A1 | GOLF BALL | SRI SPORTS LIMITED (JP) | 2012-06-07 | — | — | US | disclosed |
| CN-102485294-A | Golf ball | SRI SPORTS LTD | 2012-06-06 | — | — | CN | disclosed |
| US-6919393-B2 | Solid golf ball | SRI SPORTS LIMITED (JP) | 2005-07-19 | — | — | US | disclosed |
| US-20030144425-A1 | Solid golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2003-07-31 | — | — | US | disclosed |
| US-20030144427-A1 | Solid golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2003-07-31 | — | — | US | disclosed |
| EP-0034759-B1 | CHROMOGEN CEPHALOSPORINS AND PROCESS FOR THEIR PREPARATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-01-02 | — | — | EP | disclosed |
| US-4535156-A | DECTECTION OF BETA-LACTAMINASE AND BETA-LACTAMASE INHIBITORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-08-13 | — | — | US | disclosed |
| EP-0034759-A2 | Chromogen cephalosporins and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-09-02 | — | — | EP | disclosed |
| US-3954994-A | Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents | PFIZER INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210340158-A1 | MACROCYCLIC SPIROETHERS AS MCL-1 INHIBITORS | MCL1, BCL9, BCL9L | CASP6 1055/4885TSHR 1927/4885LMNA 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.